Skip to main content
AIDS (London, England)
Mechanistic differences underlying HIV latency in the gut and blood contribute to differential responses to latency-reversing agents.
Effects of an intervention on internalized HIV-related stigma for individuals newly entering HIV care.
Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade.
Outcomes of immunomodulatory and biologic therapy in people living with HIV: a report from two academic hospitals.
Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
Contributions of HIV, HCV, and traditional vascular risk factors to peripheral artery disease in women.
Poverty stigma is associated with suboptimal HIV care and treatment outcomes among women living with HIV in the U.S.
Longitudinal association between internalized HIV stigma and antiretroviral therapy adherence for women living with HIV: the mediating role of depression.
Aspartate aminotransferase-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men.
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.
